Volume 81, Issue 18

Search all Drugs articles

Volume 81, Issue 18

December 2021

12 articles in this issue

Acknowledgement to Referees

Acknowledgement to Referees 19 November 2021 Pages: 2077 - 2080
Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence
Shelley N. Facente
Angela M. Reiersen
Jeffrey D. Klausner
Current Opinion Open access 01 December 2021 Pages: 2081 - 2089
Part of 1 collection:

COVID-19
Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A
Nowell Solish
Jean Carruthers
Conor J. Gallagher
Leading Article Open access 17 November 2021 Pages: 2091 - 2101
Cannabis-Based Medicines and Medical Cannabis in the Treatment of Nociplastic Pain
Mary-Ann Fitzcharles
Frank Petzke
Winfried Häuser
Review Article 20 November 2021 Pages: 2103 - 2116
Part of 1 collection:

Pain and Analgesia
The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update
Dan Reynolds
Marin Kollef
Review Article 07 November 2021 Pages: 2117 - 2131
Regdanvimab: First Approval
Yahiya Y. Syed
AdisInsight Report 01 November 2021 Pages: 2133 - 2137
Part of 1 collection:

COVID-19
Correction to: Regdanvimab: First Approval
Yahiya Y. Syed
Correction 16 November 2021 Pages: 2139 - 2139
Tisotumab Vedotin: First Approval
Anthony Markham
AdisInsight Report 08 November 2021 Pages: 2141 - 2147
Abrocitinib: First Approval
Emma D. Deeks
Sean Duggan
AdisInsight Report Open access 22 November 2021 Pages: 2149 - 2157
Penpulimab: First Approval
Sohita Dhillon
AdisInsight Report 23 November 2021 Pages: 2159 - 2166
Correction to: Cefiderocol: A Review in Serious Gram-Negative Bacterial Infections
Yahiya Y. Syed
Correction Open access 18 November 2021 Pages: 2167 - 2167
Correction to: Avatrombopag: A Review in Thrombocytopenia
Anthony Markham
Correction Open access 29 November 2021 Pages: 2169 - 2169

Volume 81, Issue 18

Acknowledgement to Referees

Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence

Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A

Cannabis-Based Medicines and Medical Cannabis in the Treatment of Nociplastic Pain

The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update

Regdanvimab: First Approval

Correction to: Regdanvimab: First Approval

Tisotumab Vedotin: First Approval

Abrocitinib: First Approval

Penpulimab: First Approval

Correction to: Cefiderocol: A Review in Serious Gram-Negative Bacterial Infections

Correction to: Avatrombopag: A Review in Thrombocytopenia

Navigation